Neudle.com: multiple sclerosis epidemiology of

Differential
(Click to cross reference)

acetylcholine receptor

acetylcholine receptor antibody

acquired immunodeficiency syndrome

acquired immunodeficiency syndrome dementia complex

adverse drug reaction

algorithm

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, Parkinson-dementia-complex

analgesic

anemia

angiography, cerebral

angiography, spinal

antibodies to measles

apraxia

area postrema

area postrema syndrome

atlanto axial dislocation, congenital

autoantibodies

autoimmune disease

autonomic dysfunction

basal ganglia, lesion of

basal ganglia, lesion, bilateral

campylobacter infection

CAT scan, abnormal

cause of death

cavernous sinus, syndrome

central nervous system, infection of

cerebellar atrophy, secondary

cerebellar degeneration

cerebellar lesion

cerebral cortex

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, oligoclonal IgG in

cerebrovascular accident

cerebrovascular disease

corpus callosum, lesion of

cost

cranial neuropathy, multiple

critical care unit

cryptococcal meningitis

cytomegalovirus infection

deep gray nuclei

delirium

dementia

demyelinating disease

diagnostic criteria

diencephalon

differential diagnosis

diplopia

disability rating scale, neurological

disability, neurological

disseminated intravascular coagulation(DIC)

electroencephalogram, abnormalities of

electroencephalogram, brain mapping

electroencephalogram, periodic complexes

emergencies, neurologic

employment

encephalitis

encephalitis, bornavirus

encephalitis, human immunodeficiency virus type 1

encephalitis, viral

encephalocele

encephalopathy

encephalopathy, metabolic

endemic area

epidemiology of neurology

ergotamine

Europe

extinction on double simultaneous stimulation

fistula, arterio-venous, dural

fistula, arterio-venous, dural, spinal

gammaglobulin therapy, intravenous

gender

gray matter

Guillain Barre syndrome

Guillain Barre syndrome, complications

Guillain Barre syndrome, differential diagnosis of

Guillain Barre syndrome, etiology of

Guillain Barre syndrome, prognosis of

head injury

head injury, management of

head injury, mild

head injury, prognosis in

headache

headache, children

headache, post traumatic

headache, severe

headache, thunderclap

headache, unilateral

heatstroke

hemangioma

heralding manifestation

herpes simplex virus

herpes virus infection

herpes zoster

hiccoughs

highly active antiretroviral therapy

Hispanics

HLA

human immunodeficiency virus type 1

hypersegmented polys

hyperthermia

hypotension, systemic

hypothalamus, lesion of

immune reconstitution inflammatory syndrome

immunization, neurologic complications with

immunocompetent

immunosuppression

immunosuppressive agents

immunotherapy

inappropriate antidiuretic(A.D.H.)hormone

incidence

inclusion bodies

inclusion bodies, eosinophilic intranuclear

incontinence, fecal

infantile tremor syndrome

intellectual deficit

intellectual deterioration

intracerebral hemorrhage

Jakob-Creutzfeldt disease

JC virus

leg weakness, bilateral

life expectancy

lipoprotein receptor-related protein 4

lymphoma

lymphoma involving CNS

malformation, CNS, congenital

malformation, vascular

malformation, vascular, cerebral

medical-legal aspects of neurology

medulla oblongata

medulla oblongata, lesion of

memory, impairment of

mental status, abnormal

middle cerebellar peduncle

middle cerebellar peduncle, lesion

migraine

migraine, pathogenesis

migraine, prophylaxis

migraine, treatment of

mimics

misdiagnosis

monoclonal antibodies

mononeuropathy

mononeuropathy multiplex

mortality

motor neuron disease

motor neuron disease, juvenile form

MRI, contrast enhanced

MRI, contrast enhanced, cloud-like

MRI, diffusion weighted

MRI, field strength, high

MRI, flow void, blood

MRI, high signal foci on

MRI, high signal intensity of basal ganglia

MRI, incidental finding

MRI, lesion burden

MRI, spinal cord

MRI, spinal cord, increased intramedullary cord signal

MRI, T1 weighted high signal foci

MRS

multiple sclerosis

multiple sclerosis, asymptomatic

multiple sclerosis, cluster

multiple sclerosis, diagnosis of

multiple sclerosis, epidemiology of

multiple sclerosis, etiology of

multiple sclerosis, lesion location

multiple sclerosis, pathogenesis

multiple sclerosis, prognosis

multiple sclerosis, radiologically isolated syndrome

multiple sclerosis, treatment of

muscle weakness

MuSK antibodies

myasthenia gravis

myasthenia gravis, classification

myasthenia gravis, diagnosis

myasthenia gravis, ocular

myasthenia gravis, receptor site in

myasthenia gravis, seronegative

myasthenia gravis, thymectomy in

myasthenia gravis, treatment of

myasthenia gravis, variants

myasthenic crisis

myelitis

myelitis, longitudinal

myelitis, transverse

myelopathy

myelopathy, ascending

neoplasm, primary intracerebral

neoplasm, primary of CNS

nerve conduction studies

neurologic disease, diagnoses of

neurologic examination

neurologic signs

neurologic symptoms

neurologic testing

neuromuscular disease, electrodiagnosis of

neuromuscular junction

neuromuscular junction, abnormality of

neuromyelitis optica (Devic's disease)

neuromyelitis optica spectrum disorder

neuropathology

neuropathology, brain

neuropathy

neuropathy, sensory

nonsteroidal anti-inflammatory drug

occupational neurologic disorders

ophthalmoplegia

ophthalmoplegia, painful

opportunistic infection

opportunistic infection, CNS

optic chiasm

optic chiasm, lesion of

optic nerve, lesion of

optic neuritis

optic neuropathy

orthostatic hypotension

periaqueductal lesion

perineum, numbness of

periodic paralysis

periodic paralysis, thyrotoxic

pernicious anemia

personality change

pertussis immunization

plasmapheresis

pleocytosis of cerebrospinal fluid

post concussive syndrome

post infectious polyneuropathy

posterior leukoencephalopathy syndrome

practice guidelines

precipitating factors

pregnancy, neurologic complications in

prevention of neurologic disorders

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

proprioception, abnormal

psychological testing

psychomotor retardation

pyramidal tract dysfunction

quality of life

radicular pain

radiculitis

rapidly fatal neurologic illness

rapidly progressing neurologic illness

recurrent

rehabilitation for neurologic disorders

release phenomena

remote effect of cancer on the nervous system

renal failure

retrovirus

reversible cerebral vasoconstrictive syndromes

reversible neurologic disorder

seizure, immunization causing

sensory loss

sensory loss, cutaneous

septicemia

serologic testing

serologic testing, false negative

spinal cord, lesion of

spinal cord, vascular malformation of

spirochete infection

steroid

steroid therapy, CNS treatment and complications with

subacute myelo-opticoneuropathy(S.M.O.N.)complex

subacute sclerosing panencephalitis(S.S.P.E.)Dawson's disease

subarachnoid hemorrhage

subarachnoid hemorrhage, cerebral convexity

suicide

syphilis, diagnosis and treatment

thalamus, lesion of

thalamus, lesion of-bilateral

tick-borne encephalitis

Tolosa Hunt syndrome

toxoplasmosis, acquired

toxoplasmosis, CNS

treatment of neurologic disorder

tremor

trigeminovascular system

urinary tract infection

vaccination, neurologic complications with

vaccine

vasospasm

vasospasm, cerebral

vibratory sensation, abnormal

visuospatial disturbance

vitamin deficiency

vomiting, intractable

water channel antibodies

weakness

weakness, fatiguable

weakness, generalized

weight loss

white matter disease

white matter disease, periventricular

work loss

zinc

Showing articles 150 to 200 of 4535 << Previous Next >>

Alemtuzumab CARE-MS I 5-year follow-up
Neurol 89:1107-1116, Havrdova, E.,et al, 2017

Alemtuzumab CARE-MS II 5-year follow-up
Neurol 89:1117-1126, Coles, A.J.,et al, 2017

Five Cases of Malignant Melanoma During Fingolimod Treatment in Dutch Patients with MS
Neurol 89:970-972, Killestein, J.,et al, 2017

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
NEJM 376:221-234,280, Hauser, S.L.,et al, 2017

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
NEJM 376:209-220,280, Montalban, X.,et al, 2017

Characteristics in Limbic Encephalitis with Anti-Adenylate Kinase 5 Autoantibodies
Neurol 88:514-524,508, Do, L. & Chanson, E., 2017

Transient Smartphone Blindness: Relevance to Misdiagnosis in Neurologic Practice
Neurol 88:809-810, Sathiamoorthi, S. & Wingerchuk, D.M.,et al, 2017

Monitoring long-term Efficacy of Fampridine in Gait-Impaired Patients with Multiple Sclerosis
Neurol 88:832-841, Filli, L.,et al, 2017

Natalizumab-Associated PML
Neurol 88:1197-1205, Schwab, N.,et al, 2017

Long-Term Outcomes after Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis
JAMA Neurol 74:459-469,392, Muraro, P.A.,et al, 2017

Diagnosis of Multiple Sclerosis: Progress and Challenges
Lancet 389:1336-1346, Brownlee, W.J.,et al, 2017

High Hypothetical Interest in Physician-Assisted Death in Multiple Sclerosis
Neurol 88:1528-1534, Marrie, R.A.,et al, 2017

Powassan Virus-A New Reemerging Tick-Borne Disease
Front Public Health 5:342, Fatmi,S.S., et al, 2017

Clinical Presentation and Prognosis in MOG-antibody Disease: A UK Study
BRAIN 140:3128-3138, Jurynczyk, M.,et al, 2017

Magnetic Resonance Imaging of Cerebral Aspergillosis: Imaging and Pathological Correlations
PLoS ONE 11:DOI:10.1371/Journal.pone.0152474, Marzoif, G.,et al, 2016

Persistent Hyperthermia in a Patient with Aquaporin-4-Antibody-Positive Neuromyelitis Optica Spectrum Disorder
J Clin Neurol 12:515-516, Hsu,C-L.,et al, 2016

Long-Term Treatment of Epilepsy with Everolimus in Tuberous Sclerosis
Neurol 87:2408-2415, Krueger, D.A.,et al, 2016

Acute Cholecystitis During Treatment with Alemtuzumab in 3 Patients with RRMS
Neurol 87:2380-2381, Pfeuffer, S.,et al, 2016

Rebound Syndrome in Patients with Multiple Sclerosis after Cessation of Fingolimod Treatment
JAMA Neurol 73:790-794, Hatcher, S.E.,et al, 2016

Discriminating Long Myelitis of Neuromyelitis Optica from Sarcoidosis
Ann Neurol 79:437-447, Flanagan, E.P.,et al, 2016

Acute Disseminated Encephalomyelitis in 228 Patients
Neurol 86:2085-2096, Koelman, D.L.H.,et al, 2016

Malignancies after Mitoxantrone for Multiple Sclerosis
Neurol 86:2203-2207, Buttmann, M.,et al, 2016

Fulminant Central Nervous System Nocardiosis in a Patient Treated with Alemtuzumab for Relapsing-Remitting Multiple Sclerosis
JAMA Neurol 73:757-759, Penkert, H.,et al, 2016

Neuromyelitis Optica Spectrum Disorders
UpToDate, May, Glisson,C.C., 2016

Acute Flaccid Myelitis; A Clinical Review of US Cases 2012-2015
Ann Neurol 80:326-338, Messacar, K.,et al, 2016

The Contemporary Spectrum of Multiple Sclerosis Misdiagnosis
Neurol 87:1393-1399, Solomon, A.J.,et al, 2016

Superior MRI Outcomes with Alemtuzumab Compared with Subcutaneous Interferon �-1a in MS
Neurol 87:1464-1472, Arnold, D.L.,et al, 2016

A 34-Year-Old Man with Headache, Diploplia, and Hemiparesis
Neurol 86:e28, Lincoln, M.R.,et al, 2016

Neuromyelitis Optica: Evaluation of 871 Attacks and 1,153 Treatment Courses
Ann Neurol 79:206-216,204, Kleiter, I.,et al, 2016

Responsibilities of Health Care PRofessionals in Counseling and Educating Patients with Incurable Neurological Diseases Regarding "Stem Cell Tourism"
JAMA Neurol 72:1342-1345, Bowman, M.,et al, 2015

Acute Flaccid Myelitis of Unknown Etiology in California 2012-2015
JAMA 314:2663-2671, Van Haren, K.,et al, 2015

Cardiovascular Dysfunction in Multiple Sclerosis
Neurologist 20:108-114, Kaplan, T.B.,et al, 2015

Treatment Outcomes with Rituximab in 100 Patients with Neuromyelitis Optica
JAMA Neurol 72:989-995, Kim, S.H.,et al, 2015

Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis
NEJM 373:1418-1428, Kappos, L.,et al, 2015

Isolated Lingual Dyskinesia in Multiple Sclerosis
JAMA Neurol 72:1196-1197, Park, J.E.,et al, 2015

Cryptococcal Meningoencephalitis in a Patient with Multiple Sclerosis Treated with Fingolimod
JAMA Neurol 72:1203-1205, Zhan, Y.,et al, 2015

Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke
NEJM 372:2285-2295,2347, Saver, J.L.,et al, 2015

Thrombectomy within 8 hours after Symptom Onset in Ischemic Stroke
NEJM 372:2296-2306,2347, Jovin, T.G.,et al, 2015

Neurological Manifestations of Scrub Typhus
JNNP 86:761-766, Misra, U.K.,et al, 2015

Outcome Following Decompressive Hemicraniectomy for Malignant Cerebral Infarction
Stroke 46:2695-26598, Honeybul, S.,et al, 2015

Oral Versus Intravenous High-Dose Methylprednisolone for Treatment of Relapses in Patients with Multiple Sclerosis (COPOUSEP):A Randomised, Controlled, Double-Blind,Non-Inferiority Trial
Lancet 386:974-981, LePage,E.,et al, 2015

Relapse in Multiple Sclerosis
BMJ 350:h1765, Galea, I.,et al, 2015

Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke
NEJM 372:DOI:10.1056/NEJMoa1415061, DOI:10.1056 NEJM e1503217, Saver, J.L.,et al, 2015

Thrombectomy within 8 Hours after Symptom Onset in Ischemic Stroke
NEJM 372:DOI:10.1056 NEJMoa1503780, DOI:1056NEJM e1503217, Jovin, T.G.,et al, 2015

Newer Agents in the Treatment of Multiple Sclerosis
Neurologist 19:104-117, Pawate, S. & Bagnato F., 2015

Comparing 3T and 1.5T MRI for Mapping Hippocampal Atrophy in the Alzheimers Disease Neuroimaging Initiative
AJNR 36:653-660, Chow, N.,et al, 2015

Differential Diagnosis of Finger Drop
Neurologist 19:128-131, Varatharaj, A.,et al, 2015

Paroxysmal Dystonia as a Manifestation of Multiple Sclerosis
Neurologist 19:132-134, Machado, C.,et al, 2015

Bionic Reconstruction to Restore Hand Function After Brachial Plexus Injury: A Case Series of Three Patients
Lancet 385:2183-2189, Aszmann, O.C.,et al, 2015

Reactivation of Herpesvirus under Fingolimod: A Case of Severe Herpes Simplex Encephalitis
Neurol 84:2377-2378, Pfender, N.,et al, 2015

Showing articles 150 to 200 of 4535 << Previous Next >>